AI ASSISTANT
Ask DrugCentral
Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIYour question
Ask in your own words. Each question is answered independently.
Explore sample questions
Select a question to fill the editor, then ask it or make it your own.
DrugCentral answer
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
About Ask DrugCentral
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
General architecture
- Ask a questionThe browser sends your question to the same-origin Django chat API.
- Retrieve and generateThe API forwards the question to the configured DrugCentral retrieval-augmented generation (RAG) service, which returns an AI-generated answer.
- Explore the answerThe app resolves cited drug-card names and displays the answer with links to drug records.
Using the assistant
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
hydrogen peroxide 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 3281 | 7722-84-1 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials.
|
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 60 | mg | O |
ADMET properties:
None
Predicted pharmacokinetic/toxicological properties (PK-AZ):
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Application site discolouration | 73.09 | 35.82 | 10 | 233 | 928 | 90627276 |
| Hypertrophic scar | 64.46 | 35.82 | 6 | 237 | 12 | 90628192 |
| Application site erythema | 36.64 | 35.82 | 7 | 236 | 5201 | 90623003 |
FDA Adverse Event Reporting System (Male)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Gastritis erosive | 55.07 | 37.62 | 12 | 289 | 6491 | 42614543 |
| Shock haemorrhagic | 44.16 | 37.62 | 12 | 289 | 16230 | 42604804 |
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Gastritis erosive | 51.97 | 34.91 | 12 | 532 | 11988 | 110576767 |
| Shock haemorrhagic | 46.76 | 34.91 | 13 | 531 | 27234 | 110561521 |
| Hypertrophic scar | 39.62 | 34.91 | 4 | 540 | 11 | 110588744 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | A01AB02 | ALIMENTARY TRACT AND METABOLISM STOMATOLOGICAL PREPARATIONS STOMATOLOGICAL PREPARATIONS Antiinfectives and antiseptics for local oral treatment |
| ATC | D08AX01 | DERMATOLOGICALS ANTISEPTICS AND DISINFECTANTS ANTISEPTICS AND DISINFECTANTS Other antiseptics and disinfectants |
| ATC | D11AX25 | DERMATOLOGICALS OTHER DERMATOLOGICAL PREPARATIONS OTHER DERMATOLOGICAL PREPARATIONS Other dermatologicals |
| ATC | S02AA06 | SENSORY ORGANS OTOLOGICALS ANTIINFECTIVES Antiinfectives |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000891 | Anti-Infective Agents, Local |
| MeSH PA | D016877 | Oxidants |
| CHEBI has role | CHEBI:23357 | cofactor |
| CHEBI has role | CHEBI:33281 | antimicrobial agent |
| CHEBI has role | CHEBI:48219 | disinfectant |
| CHEBI has role | CHEBI:50902 | genotoxin |
| CHEBI has role | CHEBI:50910 | neurotoxin |
| CHEBI has role | CHEBI:59163 | biomarker |
| CHEBI has role | CHEBI:63248 | oxidising agent |
| CHEBI has role | CHEBI:63490 | explosive |
| CHEBI has role | CHEBI:65259 | GABA antagonist |
| CHEBI has role | CHEBI:68495 | apoptosis inducer |
| CHEBI has role | CHEBI:75771 | mouse metabolite |
| CHEBI has role | CHEBI:75772 | <em>Saccharomyces cerevisiae </em> metabolite |
| CHEBI has role | CHEBI:76967 | human xenobiotic metabolite |
| CHEBI has role | CHEBI:76971 | <em>Escherichia coli</em> metabolite |
| CHEBI has role | CHEBI:132717 | bleaching agent |
| CHEBI has role | CHEBI:149552 | emetic |
Related Drugs by ATC class:
A01AB Antiinfectives and antiseptics for local oral treatment 22 drugs
D08AX Other antiseptics and disinfectants 7 drugs
D11AX Other dermatologicals 20 drugs
S02AA Antiinfectives 17 drugs
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Antiseptic preparation | indication | 261276004 |
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Fish | Control mortality caused by saprolegniasis | Indication |
| Fish | Control mortality caused by bacterial gill disease associated with Flavobacterium branchiophilum | Indication |
| Fish | Control mortality caused by saprolegniasis | Indication |
| Fish | Control mortality caused by external columnaris disease associated with Flavobacterium columnare (Flexibacter columnaris) | Indication |
| Fish | Control mortality caused by external columnaris disease associated with Flavobacterium columnare (Flexibacter columnaris) | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| 35% PEROX-AID | Syndel USA | 1 |
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 4.99 | acidic |
| pKa2 | 12.0 | acidic |
Orange Book patent data (new drug applications)
| Formulation strength | Trade name | Applicant | Application number | Approval date | Type | Dose form | Route | Patent number | Patent expiration date | Patent use |
|---|---|---|---|---|---|---|---|---|---|---|
| 40% | ESKATA | ACLARIS | N209305 | Dec. 14, 2017 | DISCN | SOLUTION | TOPICAL | 10098910 | April 21, 2035 | TREATMENT OF SEBORRHEIC KERATOSES THAT ARE RAISED |
| 40% | ESKATA | ACLARIS | N209305 | Dec. 14, 2017 | DISCN | SOLUTION | TOPICAL | 9980983 | April 21, 2035 | TREATMENT OF SEBORRHEIC KERATOSES THAT ARE RAISED |
| 40% | ESKATA | ACLARIS | N209305 | Dec. 14, 2017 | DISCN | SOLUTION | TOPICAL | 9675639 | July 4, 2035 | TREATMENT OF SEBORRHEIC KERATOSES THAT ARE RAISED |
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| BBX060AN9V | UNII |
| D00008 | KEGG_DRUG |
| 4019590 | VANDF |
| C0020281 | UMLSCUI |
| CHEBI:16240 | CHEBI |
| PEO | PDB_CHEM_ID |
| CHEMBL71595 | ChEMBL_ID |
| 784 | PUBCHEM_CID |
| DB11091 | DRUGBANK_ID |
| D006861 | MESH_DESCRIPTOR_UI |
| 372426 | RXNORM |
| 35389 | MMSL |
| 35390 | MMSL |
| 4847 | MMSL |
| 5359 | MMSL |
| 003157 | NDDF |
| 31231007 | SNOMEDCT_US |
| 387171003 | SNOMEDCT_US |
| BBX060AN9V | INXIGHT DRUGS |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| PEROXYL MOUTH SORE MILD MINT | HUMAN OTC DRUG LABEL | 1 | 0126-0083 | RINSE | 15 mg | BUCCAL | OTC MONOGRAPH NOT FINAL | 13 sections |
| PEROXYL MOUTH SORE MILD MINT | HUMAN OTC DRUG LABEL | 1 | 0126-0083 | RINSE | 15 mg | BUCCAL | OTC MONOGRAPH NOT FINAL | 13 sections |
| Sore Mouth Cleanser | HUMAN OTC DRUG LABEL | 1 | 0363-0085 | MOUTHWASH | 15 mg | TOPICAL | OTC Monograph Drug | 12 sections |
| Hydrogen Peroxide3 Percent | HUMAN OTC DRUG LABEL | 1 | 0363-0268 | LIQUID | 2.65 mL | TOPICAL | OTC Monograph Drug | 13 sections |
| Hydrogen Peroxide | HUMAN OTC DRUG LABEL | 1 | 0363-0871 | SOLUTION | 30 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Oral Sore Antiseptic | HUMAN OTC DRUG LABEL | 2 | 0363-1045 | LIQUID | 1.50 mg | ORAL | OTC Monograph Drug | 13 sections |
| Walgreens 3 Hydrogen Peroxide Wipes | HUMAN OTC DRUG LABEL | 1 | 0363-9653 | CLOTH | 0.03 g | TOPICAL | OTC Monograph Drug | 13 sections |
| Humco Hydrogen Peroxide | HUMAN OTC DRUG LABEL | 1 | 0395-1113 | LIQUID | 30 mg | TOPICAL | OTC Monograph Drug | 12 sections |
| Humco Hydrogen Peroxide | HUMAN OTC DRUG LABEL | 1 | 0395-9116 | LIQUID | 30 mg | TOPICAL | OTC monograph not final | 12 sections |
| Hydrogen Peroxide | HUMAN OTC DRUG LABEL | 1 | 0404-0001 | SOLUTION | 30 mg | TOPICAL | OTC Monograph Drug | 14 sections |
| Hydrogen Peroxide | HUMAN OTC DRUG LABEL | 1 | 0869-0871 | SOLUTION | 30 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| First Aid Only Hydrogen Peroxide | HUMAN OTC DRUG LABEL | 1 | 0924-0171 | SPRAY | 30 mL | TOPICAL | OTC monograph not final | 11 sections |
| Hydrogen Peroxide Antiseptic | HUMAN OTC DRUG LABEL | 1 | 0924-0932 | SPRAY | 30 mL | TOPICAL | OTC monograph not final | 11 sections |
| First Aid Only Hydrogen Peroxide 3% | HUMAN OTC DRUG LABEL | 1 | 0924-0935 | SPRAY | 30 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Perio Armor | HUMAN OTC DRUG LABEL | 1 | 10129-018 | GEL | 17 g | PERIODONTAL | unapproved drug other | 12 sections |
| Perio Armor | HUMAN OTC DRUG LABEL | 1 | 10129-019 | GEL | 17 g | DENTAL | unapproved drug other | 12 sections |
| Perio Armor | HUMAN OTC DRUG LABEL | 1 | 10129-020 | GEL | 17 g | DENTAL | unapproved drug other | 12 sections |
| Perio Armor | HUMAN OTC DRUG LABEL | 1 | 10129-032 | GEL | 17 g | DENTAL | unapproved drug other | 12 sections |
| Perio Armor-X | HUMAN OTC DRUG LABEL | 1 | 10129-038 | GEL | 1.70 g | PERIODONTAL | OTC monograph not final | 12 sections |
| Perio Armor-X | HUMAN OTC DRUG LABEL | 1 | 10129-039 | GEL | 1.70 g | PERIODONTAL | OTC monograph not final | 12 sections |
| Perio Armor-X | HUMAN OTC DRUG LABEL | 1 | 10129-042 | GEL | 1.70 g | PERIODONTAL | OTC monograph not final | 12 sections |
| Perio Plus | HUMAN OTC DRUG LABEL | 1 | 10129-043 | GEL | 1.70 g | DENTAL | OTC monograph not final | 12 sections |
| Perio Max Plus | HUMAN OTC DRUG LABEL | 1 | 10129-044 | GEL | 1.70 g | DENTAL | OTC monograph not final | 12 sections |
| Hydrogen Peroxide | HUMAN OTC DRUG LABEL | 1 | 10202-001 | SOLUTION | 30 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Orajel Antiseptic Rinse For All Mouth Sores | HUMAN OTC DRUG LABEL | 2 | 10237-760 | LIQUID | 15 mg | ORAL | OTC Monograph Drug | 12 sections |
| Orajel Antiseptic Alcohol-Free Mouth Sore Rinse | HUMAN OTC DRUG LABEL | 2 | 10237-784 | LIQUID | 15 mg | ORAL | OTC Monograph Drug | 11 sections |
| Orajel 2x Gum Pain Alcohol-Free | HUMAN OTC DRUG LABEL | 2 | 10237-799 | RINSE | 15 mg | ORAL | OTC Monograph Drug | 14 sections |
| Hydrogen Peroxide | HUMAN OTC DRUG LABEL | 1 | 10565-001 | SOLUTION | 3 mL | TOPICAL | OTC Monograph Drug | 14 sections |
| Hydrogen Peroxide | HUMAN OTC DRUG LABEL | 1 | 11344-871 | SOLUTION | 30 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Hydrogen Peroxide3 Percent | HUMAN OTC DRUG LABEL | 1 | 11673-268 | LIQUID | 2.65 mL | TOPICAL | OTC Monograph Drug | 13 sections |